Barry S. Rosenstein

Papers

Total Citations

H-Index

About

Barry S. Rosenstein is a leading researcher in radiation oncology, with key contributions to the quantification of DNA damage and the advancement of stereotactic radiosurgery. His work focuses on developing innovative methods to assess and treat radiation-induced cellular responses, particularly in cancer therapy. Rosenstein's major contributions include the development of an automated γ-H2AX immunocytochemistry assay, a groundbreaking tool that quantifies double-strand breaks caused by ionizing radiation. This assay, detailed in his 2009 paper (38 citations), enables high-throughput analysis of DNA damage in prostate cancer cells, such as PC-3 and DU145, offering broad applications for evaluating physiological responses to radiation. Additionally, his 2008 study on stereotactic radiosurgery for thoracic malignancies (20 citations) highlights his expertise in precision radiation techniques for treating lung and chest tumors. Rosenstein's work has significantly impacted the field by providing reproducible, automated methods to monitor radiation effects, thereby improving treatment planning and patient outcomes. His achievements underscore a commitment to bridging laboratory research and clinical practice, making him a notable figure in radiation biology and oncology.